ONO
Ono Pharmaceutical Co., Ltd.
| Research |
OneLook
Acronym Finder
|
| Serial Number | 79379120 |
| Mark Drawing Code | 3000: Illustration: Drawing or design which also includes word(s)/ letter(s)/number(s) |
Timeline
| 2023-04-03 | Application Filed |
| 2023-09-21 | Location: INITIAL REVIEW/SERIALIZATION BRANCH(MAILROOM) |
| 2023-09-21 | Status: Live/Pending |
| 2023-09-29 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  ONO PHARMACEUTICAL CO., LTD. |
| Address | 1-5, Doshomachi 2-chome, Chuo-ku, Osaka-shi Osaka 541-8526 JP |
| Legal Entity Type | Corporation |
| Legal Entity State | JP |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Design Search Codes
| 260901 | Squares as carriers or squares as single or multiple line borders |
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 005,006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | Pharmaceutical preparations; pharmaceutical substances; anti-cancer preparations; chemical preparations for sanitary purposes; chemical preparations for medicinal purposes; diagnostic preparations for medical purposes; medicines for veterinary purposes; medicated toiletry preparations; sanitary preparations for medical purposes; fungicides; sterilizing preparations; disinfectants for hygiene purposes; pharmaceutical preparations for the treatment and prevention of cardiovascular disorders, genitourinary disorders, gynecological diseases and obstetric diseases, cancer and its metastasis, eye disorders, neurologic disorders, psychiatric disorders, endocrine and metabolic disorders, allergic disorders, gastrointestinal disorders, immune diseases and autoimmune diseases, respiratory diseases, musculoskeletal and connective tissue disorders, infectious diseases, dermatologic disorders, hematological disorder, inflammatory diseases, ear, nose, dental and throat disorders, hepatic and biliary disorders, Alzheimer's disease, and diabetes and its complications; pharmaceutical preparations for cancer supportive care; anesthetic, sedative and analgesic drugs; vaccines; glucose dietary supplements; lecithin dietary supplements; nutritional supplements; dietary supplements mainly consisting of seafood extracts in the form of powders, pills, capsules, granules, jellies or liquids; dietary supplements for humans; dietary fibre; lyophilised food adapted for medical purposes; lyophilised meat adapted for medical purposes; dietetic beverages adapted for medical purposes; dietetic foods adapted for medical purposes; beverages for babies; food for babies |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| SN ASSIGNED FOR SECT 66A APPL FROM IB | 2023-09-21 | 1 REPR M: |
| LIMITATION FROM ORIGINAL APPLICATION ENTERED | 2023-09-25 | 2 LIMI I:Incoming Correspondence |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | 2023-09-29 | 3 NWOS I:Incoming Correspondence |
| APPLICATION FILING RECEIPT MAILED | 2023-10-03 | 4 MAFR O:Outgoing Correspondence |
| ASSIGNED TO EXAMINER | 2023-10-17 | 5 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2023-10-26 | 6 CNRT R:Renewal |
| NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | 2023-10-27 | 7 RFCR E:E-Mail |
| REFUSAL PROCESSED BY MPU | 2023-10-30 | 8 RFRR P: |
| NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | 2023-10-30 | 9 RFCS P: |
| REFUSAL PROCESSED BY IB | 2023-11-22 | 10 RFNT P: |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2024-04-10 | 11 TROA I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2024-04-10 | 12 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2024-04-10 | 13 TEME I:Incoming Correspondence |
| EXAMINERS AMENDMENT -WRITTEN | 2024-04-15 | 14 CNEA R:Renewal |
| EXAMINERS AMENDMENT E-MAILED | 2024-04-15 | 15 GNEA O:Outgoing Correspondence |
| NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 2024-04-15 | 16 GNEN O:Outgoing Correspondence |
| EXAMINER'S AMENDMENT ENTERED | 2024-04-15 | 17 XAEC I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2024-04-15 | 18 CNSA O:Outgoing Correspondence |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2024-05-01 | 19 NONP E:E-Mail |
| PUBLISHED FOR OPPOSITION | 2024-05-21 | 20 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2024-05-21 | 21 NPUB E:E-Mail |
Similar Marks
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 